Correlation Between Blueprint Medicines and Prometheus Biosciences
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Prometheus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Prometheus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Prometheus Biosciences, you can compare the effects of market volatilities on Blueprint Medicines and Prometheus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Prometheus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Prometheus Biosciences.
Diversification Opportunities for Blueprint Medicines and Prometheus Biosciences
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Blueprint and Prometheus is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Prometheus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prometheus Biosciences and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Prometheus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prometheus Biosciences has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Prometheus Biosciences go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Prometheus Biosciences
If you would invest 9,275 in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of 112.00 from holding Blueprint Medicines Corp or generate 1.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 1.59% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Prometheus Biosciences
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Prometheus Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Blueprint Medicines and Prometheus Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Prometheus Biosciences
The main advantage of trading using opposite Blueprint Medicines and Prometheus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Prometheus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prometheus Biosciences will offset losses from the drop in Prometheus Biosciences' long position.| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
| Prometheus Biosciences vs. Apellis Pharmaceuticals | Prometheus Biosciences vs. Akero Therapeutics | Prometheus Biosciences vs. Immunovant | Prometheus Biosciences vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |